Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse

K. Scheinemann, P. A. Eng, W. Ruch, M. Solèr, H. E. Gnehm (Aarau, Basel, Switzerland)

Source: Annual Congress 2002 - Miscellaneous respiratory infections in children
Session: Miscellaneous respiratory infections in children
Session type: Thematic Poster Session
Number: 2102
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Scheinemann, P. A. Eng, W. Ruch, M. Solèr, H. E. Gnehm (Aarau, Basel, Switzerland). Pulmonary histiocytosis triggered by marijuana- and nicotine-abuse. Eur Respir J 2002; 20: Suppl. 38, 2102

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2006; 28: Suppl. 50, 826s
Year: 2006

Pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2008 - PG5 - Interstitial lung diseases: selected orphan diseases
Year: 2008



Pulmonary Langerhans' cell histiocytosis
Source: Eur Respir Mon; 2009: 46: 155–175
Year: 2009

Paediatric pulmonary Langerhans cell histiocytosis
Source: Breathe, 16 (2) 200003; 10.1183/20734735.0003-2020
Year: 2020



How I manage pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170070; 10.1183/16000617.0070-2017
Year: 2017



Pneumothorax in pulmonary langerhans cell histiocytosis (PLCH)
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Pulmonary Langerhans‘ cell histiocytosis (PLCH). Report of two cases diagnosed with pulmonary vascular involvement via exercise tests
Source: Annual Congress 2008 - Miscellaneous aspects of interstitial lung disease
Year: 2008


Pulmonary Langerhans‘-cell histiocytosis – clinical futures and outcome
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Clinical study of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease I
Year: 2012

Pneumothorax in patients with Langerhans cell histiocytosis
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017

Chemotherapy in patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018



Pathological findings in histiocytosis X with pulmonary hypertension
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012

Pulmonary Langerhans' cell histiocytosis
Source: Respipedia Article
Year: 2016

Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma
Source: Eur Respir Rev 2009; 19: 86-88
Year: 2010


Clinical course and outcome of pulmonary Langerhans‘-cell histiocytosis
Source: Annual Congress 2010 - Rare diffuse lung diseases
Year: 2010

Lung transplantation for pulmonary Langerhans‘ cell histiocytosis
Source: Eur Respir J 2005; 26: Suppl. 49, 635s
Year: 2005

New insights in lymphangioleiomyomatosis and pulmonary Langerhans cell histiocytosis
Source: Eur Respir Rev, 26 (145) 170042; 10.1183/16000617.0042-2017
Year: 2017



Psychological abnormalities are commonly present in adult patients with pulmonary Langerhans cell histiocytosis
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019


Genetic landscape of pulmonary langerhans cell histiocytosis
Source: International Congress 2018 – Progress in rare interstitial lung diseases
Year: 2018